These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 12013911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Single deletion of mitochondrial DNA: CPEO, Kearns-Sayre syndrome].
    Arisato T, Higuchi I, Nakagawa M.
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():458-61. PubMed ID: 12013912
    [No Abstract] [Full Text] [Related]

  • 3. [Chronic progressive external ophthalmoplegia (CPEO), Kearns-Sayre syndrome (KSS)].
    Ishikawa H, Nishino I.
    Ryoikibetsu Shokogun Shirizu; 2001 Apr; (36):153-6. PubMed ID: 11596351
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Chronic progressive external ophthalmoplegia--symptom or syndrome?].
    Bau V, Deschauer M, Zierz S.
    Klin Monbl Augenheilkd; 2009 Oct; 226(10):822-8. PubMed ID: 19830638
    [Abstract] [Full Text] [Related]

  • 7. [Autosomal dominant chronic progressive external ophthalmoplegia].
    Higuchi I, Nakagawa M.
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():450-4. PubMed ID: 12013910
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].
    Barrientos A, Casademont J, Grau JM, Cardellach F, Montoya J, Estivill X, Urbano-Márquez A, Nunes V.
    Med Clin (Barc); 1995 Jul 01; 105(5):180-4. PubMed ID: 7630231
    [Abstract] [Full Text] [Related]

  • 10. [ARCO].
    Inoue Y.
    Nihon Rinsho; 2002 Apr 01; 60 Suppl 4():367-70. PubMed ID: 12013888
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?
    Auré K, Ogier de Baulny H, Laforêt P, Jardel C, Eymard B, Lombès A.
    Brain; 2007 Jun 01; 130(Pt 6):1516-24. PubMed ID: 17439982
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy.
    Kosmorsky G, Johns DR.
    Neurol Clin; 1991 Feb 01; 9(1):147-61. PubMed ID: 2011107
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CPEO and KSS differ in the percentage and location of the mtDNA deletion.
    López-Gallardo E, López-Pérez MJ, Montoya J, Ruiz-Pesini E.
    Mitochondrion; 2009 Sep 01; 9(5):314-7. PubMed ID: 19410662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.